USMLE Exam Status
Steps 1, 2 CK and 3 - Prometric testing centers will continue to open on a site-by-site basis in accordance with state and local laws and social distancing guidelines. We have begun administration of Step 1 and Step 2 CK at three medical schools who will serve as limited testing centers in their region.
Steps 2 CS - Given the unique, human-to-human delivery mode of this exam, testing is suspended for the next 12-18 months to protect the health of examinees and test center staff.
USMLE exploring alternate test delivery options
Finding safe solutions to accommodate examinees’ testing needs has been our main focus and
highest priority over the past few months. Due to increasing uncertainty around having wider
availability of in-person testing at Prometric test centers, the USMLE program has identified several
alternate test delivery methods for Step 1, Step 2 CK, and Step 3 and has begun aggressively pursuing
them. We communicate regularly with Prometric about how the availability and timeliness of USMLE
testing contributes to a critical pipeline of much-needed healthcare workers, but we are acutely aware
that there are and will continue to be testing capacity limitations for many months. We recognize the
resulting burden on examinees and medical schools, which is why we are pursuing several alternative
test delivery methods. This work incorporates the suggestions and ideas we have received from medical
students, medical school faculty, state medical boards, and our partners.
We are exploring remote proctoring, delivery at alternate sites (including medical schools), and additional solutions to address testing backlog and capacity restraints.
We are committed to completing our analysis of these options and delivering testing solutions by June 30th. Subsequent efforts to scale these solutions to help address the backlog will occur in July. In the meantime, examinees may wish to consult their faculty advisor or student affairs dean for guidance on whether, or when, they should consider testing.
In conjunction with identifying supplemental avenues for testing, we will continue to work with organizations in the medical education and the medical regulatory community to address the disruption in USMLE availability for medical licensure and academic progression. Some solutions may involve temporary changes to policy and/or requirements, e.g., relaxing requirements for promotion, graduation, or licensing decisions.
We recognize the extraordinary and difficult circumstances facing medical students, medical educators, and medical regulators. Finding a safe solution to increase testing is our top priority. We will continue to provide updated communications regularly.